Hepsin Promotes Breast Tumor Growth Signaling via the TGFβ-EGFR Axis

Researchers demonstrated in 3D cultures of patient-derived breast cancer explants that both basal TGFβ signaling and EGFR protein expression were inhibited by neutralizing antibodies or small-molecule inhibitors of hepsin.